Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer-Response

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):977. doi: 10.1158/1055-9965.EPI-16-1026. Epub 2017 May 15.

Authors

Jessica K Paulus¹, Christina D Williams^{2

3}, Furha I Cossor⁴, Michael J Kelley^{2

3}, Robert E Martell⁴

Affiliations

¹ Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts. [email protected].
² Division of Hematology-Oncology, Durham VA Medical Center, Durham, North Carolina.
³ Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina.
⁴ Division of Hematology-Oncology, Tufts Medical Center, Boston, Massachusetts.

No abstract available

Publication types

Letter

MeSH terms

Colorectal Neoplasms / complications*
Colorectal Neoplasms / drug therapy
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / mortality
Diabetes Mellitus, Type 2 / pathology
Female
Humans
Male
Metformin / pharmacology
Metformin / therapeutic use*
United States
Veterans

Substances

Metformin

Grants and funding